Liver Care & Transplant Program | NYU Langone Health
Experts at NYU Langone’s Liver Care and Transplant Program provide screening, diagnosis, and treatment of liver diseases and liver cancer.
Liver Care & Transplant Program Doctors | NYU Langone Health
Find a doctor at the Liver Care & Transplant Program at NYU Langone.
Liver Transplant Program | NYU Langone Health
NYU Langone Transplant Institute’s doctors offer specialized liver transplant care and other types of liver surgery for adults and children.
Liver Transplant Program Doctors | NYU Langone Health
Find a doctor at the Liver Transplant Program at NYU Langone.
Liver Tumor Program | NYU Langone Health
Liver Tumor Program specialists at NYU Langone’s Perlmutter Cancer Center provide treatment for liver, biliary tract, and gallbladder tumors.
Local Therapies for Kaposi Sarcoma | NYU Langone Health
NYU Langone doctors may use local therapies to manage a few Kaposi sarcoma lesions on the skin or in the mouth.
Locations Directory | NYU Langone Health
View our directory of NYU Langone locations across the New York City area and in Florida, and find locations by borough and neighborhood.
Locus-coeruleus function in normal elderly and AD risk (LEAD)
Growing evidence suggests that Alzheimer’s disease (AD) pathological changes begin decades before clinical symptoms and tau abnormalities in the locus coeruleus (LC) can be observed since midlife. We have previously demonstrated functional vulnerability of the LC to aging and stress, as well as an association between higher CSF tau and impaired sleep phenomena influenced by the LC. We now aim to test whether LC dysfunction can be measured in preclinical AD stages by LC targeted imaging, and whether it objectively affects sleep architecture and attention; by asking 30 cognitively normal older adults to perform a full clinical evaluation, one night of polysomnography, a lumbar puncture (LP) to obtain cerebrospinal fluid, [11C]MRB PET-MR, as well as attention testing.
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT CJS)
This study seeks to meaningfully address the U.S. opioid epidemic by comparing the effectiveness of two medications used to treat opioid use disorder, extended-release buprenorphine (XR-B) vs. extended-release naltrexone (XR-NTX), among adults currently incarcerated in U.S. jails and prisons at 5 distinct trial sites. This open-label, non-inferiority, head-to-head study design will allow providers, correctional and public health authorities, payers and policy makers' timely and relevant data to assess the effectiveness of XR-B (and XR-NTX) as potentially useful re-entry treatment option. Considering the majority of opioid users leaving jail or prison will inevitably return to their homes and communities untreated and prone to relapse, we believe findings from with important implications for limiting the greater public safety and societal costs of heroin, fentanyl, and prescription opioid addictions. Comparing retention-in-study-medication treatment, we hypothesize XR-B is non-inferior to XR-NTX.
Long-term Cardiac Device Lead Management | NYU Langone Health
NYU Langone electrophysiologists are experienced in safely replacing cardiac device batteries or leads when necessary.